Copyright Reports & Markets. All rights reserved.

Global and United States Biologics in Spine Surgery Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Biologics in Spine Surgery Product Introduction
    • 1.2 Global Biologics in Spine Surgery Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Biologics in Spine Surgery Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Biologics in Spine Surgery Sales in Volume for the Year 2017-2028
    • 1.3 United States Biologics in Spine Surgery Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Biologics in Spine Surgery Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Biologics in Spine Surgery Sales in Volume for the Year 2017-2028
    • 1.4 Biologics in Spine Surgery Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Biologics in Spine Surgery in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Biologics in Spine Surgery Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Biologics in Spine Surgery Market Dynamics
      • 1.5.1 Biologics in Spine Surgery Industry Trends
      • 1.5.2 Biologics in Spine Surgery Market Drivers
      • 1.5.3 Biologics in Spine Surgery Market Challenges
      • 1.5.4 Biologics in Spine Surgery Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Biologics in Spine Surgery Market Segment by Type
      • 2.1.1 Bone Graft
      • 2.1.2 Bone Graft Substitute
      • 2.1.3 Platelet Rich Plasma (PRP)
      • 2.1.4 Other
    • 2.2 Global Biologics in Spine Surgery Market Size by Type
      • 2.2.1 Global Biologics in Spine Surgery Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Biologics in Spine Surgery Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Biologics in Spine Surgery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Biologics in Spine Surgery Market Size by Type
      • 2.3.1 United States Biologics in Spine Surgery Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Biologics in Spine Surgery Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Biologics in Spine Surgery Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Biologics in Spine Surgery Market Segment by Application
      • 3.1.1 Hospital
      • 3.1.2 Clinic
      • 3.1.3 Other
    • 3.2 Global Biologics in Spine Surgery Market Size by Application
      • 3.2.1 Global Biologics in Spine Surgery Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Biologics in Spine Surgery Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Biologics in Spine Surgery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Biologics in Spine Surgery Market Size by Application
      • 3.3.1 United States Biologics in Spine Surgery Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Biologics in Spine Surgery Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Biologics in Spine Surgery Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Biologics in Spine Surgery Competitor Landscape by Company

    • 4.1 Global Biologics in Spine Surgery Market Size by Company
      • 4.1.1 Top Global Biologics in Spine Surgery Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Biologics in Spine Surgery Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Biologics in Spine Surgery Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Biologics in Spine Surgery Price by Manufacturer (2017-2022)
    • 4.2 Global Biologics in Spine Surgery Concentration Ratio (CR)
      • 4.2.1 Biologics in Spine Surgery Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Biologics in Spine Surgery in 2021
      • 4.2.3 Global Biologics in Spine Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Biologics in Spine Surgery Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Biologics in Spine Surgery Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Biologics in Spine Surgery Product Type
      • 4.3.3 Date of International Manufacturers Enter into Biologics in Spine Surgery Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Biologics in Spine Surgery Market Size by Company
      • 4.5.1 Top Biologics in Spine Surgery Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Biologics in Spine Surgery Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Biologics in Spine Surgery Sales by Players (2020, 2021 & 2022)

    5 Global Biologics in Spine Surgery Market Size by Region

    • 5.1 Global Biologics in Spine Surgery Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Biologics in Spine Surgery Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Biologics in Spine Surgery Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Biologics in Spine Surgery Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Biologics in Spine Surgery Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Biologics in Spine Surgery Sales in Value by Region: 2017-2022
      • 5.3.2 Global Biologics in Spine Surgery Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Biologics in Spine Surgery Market Size YoY Growth 2017-2028
      • 6.1.2 North America Biologics in Spine Surgery Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Biologics in Spine Surgery Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Biologics in Spine Surgery Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Biologics in Spine Surgery Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Biologics in Spine Surgery Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Biologics in Spine Surgery Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Biologics in Spine Surgery Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Biologics in Spine Surgery Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Biologics in Spine Surgery Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Medtronic
      • 7.1.1 Medtronic Corporation Information
      • 7.1.2 Medtronic Description and Business Overview
      • 7.1.3 Medtronic Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Medtronic Biologics in Spine Surgery Products Offered
      • 7.1.5 Medtronic Recent Development
    • 7.2 J &J (DePuy Synthes)
      • 7.2.1 J &J (DePuy Synthes) Corporation Information
      • 7.2.2 J &J (DePuy Synthes) Description and Business Overview
      • 7.2.3 J &J (DePuy Synthes) Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 J &J (DePuy Synthes) Biologics in Spine Surgery Products Offered
      • 7.2.5 J &J (DePuy Synthes) Recent Development
    • 7.3 SeaSpine
      • 7.3.1 SeaSpine Corporation Information
      • 7.3.2 SeaSpine Description and Business Overview
      • 7.3.3 SeaSpine Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 SeaSpine Biologics in Spine Surgery Products Offered
      • 7.3.5 SeaSpine Recent Development
    • 7.4 Xtant Medical
      • 7.4.1 Xtant Medical Corporation Information
      • 7.4.2 Xtant Medical Description and Business Overview
      • 7.4.3 Xtant Medical Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Xtant Medical Biologics in Spine Surgery Products Offered
      • 7.4.5 Xtant Medical Recent Development
    • 7.5 Zimmer Biomet
      • 7.5.1 Zimmer Biomet Corporation Information
      • 7.5.2 Zimmer Biomet Description and Business Overview
      • 7.5.3 Zimmer Biomet Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Zimmer Biomet Biologics in Spine Surgery Products Offered
      • 7.5.5 Zimmer Biomet Recent Development
    • 7.6 Stryker
      • 7.6.1 Stryker Corporation Information
      • 7.6.2 Stryker Description and Business Overview
      • 7.6.3 Stryker Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Stryker Biologics in Spine Surgery Products Offered
      • 7.6.5 Stryker Recent Development
    • 7.7 Straumann
      • 7.7.1 Straumann Corporation Information
      • 7.7.2 Straumann Description and Business Overview
      • 7.7.3 Straumann Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Straumann Biologics in Spine Surgery Products Offered
      • 7.7.5 Straumann Recent Development
    • 7.8 Wright Medical Group
      • 7.8.1 Wright Medical Group Corporation Information
      • 7.8.2 Wright Medical Group Description and Business Overview
      • 7.8.3 Wright Medical Group Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Wright Medical Group Biologics in Spine Surgery Products Offered
      • 7.8.5 Wright Medical Group Recent Development
    • 7.9 Hans Biomed
      • 7.9.1 Hans Biomed Corporation Information
      • 7.9.2 Hans Biomed Description and Business Overview
      • 7.9.3 Hans Biomed Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Hans Biomed Biologics in Spine Surgery Products Offered
      • 7.9.5 Hans Biomed Recent Development
    • 7.10 Arthrex
      • 7.10.1 Arthrex Corporation Information
      • 7.10.2 Arthrex Description and Business Overview
      • 7.10.3 Arthrex Biologics in Spine Surgery Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Arthrex Biologics in Spine Surgery Products Offered
      • 7.10.5 Arthrex Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Biologics in Spine Surgery Industry Chain Analysis
    • 8.2 Biologics in Spine Surgery Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Biologics in Spine Surgery Distributors
    • 8.3 Biologics in Spine Surgery Production Mode & Process
    • 8.4 Biologics in Spine Surgery Sales and Marketing
      • 8.4.1 Biologics in Spine Surgery Sales Channels
      • 8.4.2 Biologics in Spine Surgery Distributors
    • 8.5 Biologics in Spine Surgery Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
      Market Analysis and Insights: Global and United States Biologics in Spine Surgery Market
      This report focuses on global and United States Biologics in Spine Surgery market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Biologics in Spine Surgery market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Bone Graft accounting for % of the Biologics in Spine Surgery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Biologics in Spine Surgery market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Biologics in Spine Surgery Scope and Market Size
      Biologics in Spine Surgery market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biologics in Spine Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Biologics in Spine Surgery market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Biologics in Spine Surgery market is segmented into
      Bone Graft
      Bone Graft Substitute
      Platelet Rich Plasma (PRP)
      Other
      Segment by Application, the Biologics in Spine Surgery market is segmented into
      Hospital
      Clinic
      Other
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Biologics in Spine Surgery Market Share Analysis
      Biologics in Spine Surgery market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Biologics in Spine Surgery business, the date to enter into the Biologics in Spine Surgery market, Biologics in Spine Surgery product introduction, recent developments, etc.
      The major vendors covered:
      Medtronic
      J &J (DePuy Synthes)
      SeaSpine
      Xtant Medical
      Zimmer Biomet
      Stryker
      Straumann
      Wright Medical Group
      Hans Biomed
      Arthrex
      Buy now